# Thrombosis Research Institute

**Type:** Institutions  
**Canonical URL:** https://scholariq.org/institutions/thrombosis-research-institute/

## Facts

| Field | Value |
| --- | --- |
| Avg h-index | 76.3 |
| Citations | 392,169 |
| City | London |
| Country | GB |
| Description | Thrombosis Research Institute is a research organisation in London, GB. OpenAlex records 2,869 works and 392,169 citations for it. 663 researchers list it as their most recent affiliation. |
| Homepage | http://www.tri-london.ac.uk/ |
| OpenAlex ID | https://openalex.org/I4210139260 |
| Researchers | 663 |
| ROR ID | https://ror.org/050r8mq79 |
| Type | nonprofit |
| Works | 2,869 |

## University papers

- [Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE)](https://scholariq.org/papers/prediction-of-risk-of-death-and-myocardial-infarction-in-the-six-months-after/)
- [A Validated Prediction Model for All Forms of Acute Coronary Syndrome](https://scholariq.org/papers/a-validated-prediction-model-for-all-forms-of-acute-coronary-syndrome/)
- [Predictors of Outcome in Patients With Acute Coronary Syndromes Without Persistent ST-Segment Elevation](https://scholariq.org/papers/predictors-of-outcome-in-patients-with-acute-coronary-syndromes-without/)
- [Rivaroxaban for Thromboprophylaxis in High-Risk Ambulatory Patients with Cancer](https://scholariq.org/papers/rivaroxaban-for-thromboprophylaxis-in-high-risk-ambulatory-patients-with-cancer/)
- [2019 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer](https://scholariq.org/papers/2019-international-clinical-practice-guidelines-for-the-treatment-and/)
- [2022 international clinical practice guidelines for the treatment and prophylaxis of venous thromboembolism in patients with cancer, including patients with COVID-19](https://scholariq.org/papers/2022-international-clinical-practice-guidelines-for-the-treatment-and/)
- [Contrast Nephrotoxicity: A Randomized Controlled Trial of a Nonionic and an Ionic Radiographic Contrast Agent](https://scholariq.org/papers/contrast-nephrotoxicity-a-randomized-controlled-trial-of-a-nonionic-and-an-ionic/)
- [Balloon aortic valvuloplasty in adults: Failure of procedure to improve long-term survival](https://scholariq.org/papers/balloon-aortic-valvuloplasty-in-adults-failure-of-procedure-to-improve-long-term/)
- [Cause of Death and Predictors of All‐Cause Mortality in Anticoagulated Patients With Nonvalvular Atrial Fibrillation: Data From ROCKET AF](https://scholariq.org/papers/cause-of-death-and-predictors-of-all-cause-mortality-in-anticoagulated-patients/)

## University top topics

Showing 8 of 25.

- [Venous Thromboembolism Diagnosis and Management](https://scholariq.org/topics/venous-thromboembolism-diagnosis-and-management/)
- [Blood Coagulation and Thrombosis Mechanisms](https://scholariq.org/topics/blood-coagulation-and-thrombosis-mechanisms/)
- [Atrial Fibrillation Management and Outcomes](https://scholariq.org/topics/atrial-fibrillation-management-and-outcomes/)
- [Platelet Disorders and Treatments](https://scholariq.org/topics/platelet-disorders-and-treatments/)
- [Antiplatelet Therapy and Cardiovascular Diseases](https://scholariq.org/topics/antiplatelet-therapy-and-cardiovascular-diseases/)
- [Blood properties and coagulation](https://scholariq.org/topics/blood-properties-and-coagulation/)
- [Hemophilia Treatment and Research](https://scholariq.org/topics/hemophilia-treatment-and-research/)
- [Heparin-Induced Thrombocytopenia and Thrombosis](https://scholariq.org/topics/heparin-induced-thrombocytopenia-and-thrombosis/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.